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Abstract
Introduction: Children with complex urinary tract stones present a treatment challenge. There is still no
clear consensus regarding their management. Therefore, our goal was to review the endourological therapies
in children presenting with complex nephrolithiasis, updated to 2013.
Methods: This was a review of published articles, from 1981 to 2013, related to pediatric nephrolithiasis,
staghorn calculi, lower pole kidney stones, and uninephric children. The sites from which information was
retrieved covered PubMed, the American Urological Association, and Medline.
Results: We reviewed 147 articles that demonstrated that small lower pole stones of <1 cm may be treated
successfully with ESWL in children who are able to cooperate or under sedation; staghorn stones, are
better treated by PCNL. Flexible ureterorenoscopy is considered a second option for smaller stones and an
alternative for middle size stones in case of failure of ESWL or contraindications for PCNL.
Conclusion: ESWL alone, for a large stone, or in a lower pole in uninephric children is not the stan-
dard of care. PCNL offer an appropriate and therapeutic modality in specific situation i.e. larger stones,
the lower pole stones with stone free rate approaching 80%. Nevertheless, flexible ureteroscopy with the
newest high definition cameras has a promising potential in reaching a 100% stone-free rate in the near
gical
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C-NDfuture.
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ntroduction
Nephrolithiasis occurs in around 1% of children and about 5–9%
f adults” [1,2]. The incidence is higher in countries with low socio-
conomic status [3], and in countries with high temperatures and hot
limate like the Middle East, and Far East [1,2]. Children have been
eported to present from the first visit with large staghorn calculi in
lmost 20% of the cases [4]. These cases represent a real challenge
o the urologic surgeon, therefore a highly skilled and fellowship-
 license.rained endourologist should to be consulted.
hese complex cases become more problematic when a large stone
urden is present in uninephric children, and their management more
6 N. Khater et al.
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Table 1 Criteria associated with the lowest SFR during ESWL
for lower pole kidney stone in children with a solitary kidney.
Long lower pole (>1 cm)
Infundibular length of <3 cm
Steep infundibulo-pelvic angle <45degrees
Infundibular width <5 mm
Resistant stones in children (cystine, calcium oxalate monohydrate,. . .).
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roblematic. Solitary kidneys are the result of either congenital renal
nomalies or acquired renal diseases. For decades, and before the
ra of endourology and minimally invasive therapies, kidney stones
n children have been treated by open surgery. Uninephric patients
resenting with large kidney stones or staghorn calculi were ini-
ially treated with techniques including open nephrolithotomy and
yelolithotomy.
ince its introduction in the early 1980s ESWL replaced open
urgery and even PCNL as the preferred modality for the treatment
f upper tract stones [5–7].
owadays, ESWL is considered an optimal method for the treat-
ent of mid-sized and small upper tract stones. However, ESWL
as shown to have limits and shortcomings for stones with a large
urden, in a solitary kidney, or in lower poles, or even when the
tone composition is an obstacle (cystine, calcium oxalate monohy-
rate). In parallel, endourological modalities have flourished and
xpanded, including rigid and flexible ureterorenoscopy (fURS)
8–10], in addition to percutaneous nephrolithotomy (PCNL) that
as introduced in the 1970s. On the other hand, when considering
ephrolithiasis in a solitary kidney, multiple other factors should
e taken into consideration, in order to choose the best therapeutic
ption, including the renal anatomy, obesity of the pediatric patients
f present, equipment and the surgeon’s expertise and skill [11].
herefore, the objective of the present review was to detail current
echniques and results, including ESWL, fURS, PCNL, discussing
he efficacy and disadvantages of each procedure, with future trends,
or the treatment of children presenting with complex nephrolithi-
sis, including lower pole stone or staghorn calculi, and solitary
idneys, as updated to 2013.
ethods
e performed a literature search of papers published between 1981
nd 2013, and included 147 results, between published papers and
uidelines, in our review. Around 200 papers were identified in
ur literature search. The criteria for inclusion of a paper in our
eview were the presence of the combination of the following key
ords: solitary kidney, pediatric nephrolithiasis, lower pole, per-
utaneous nephrolithotomy, extra-corporeal shock wave lithotripsy,
reteroscopy, and staghorn calculus.
he information covered was retrieved electronic Database such as
ubMed, Medline, Medscape, Cochrane database, and the American
rological Association. Some articles were identified using table
f contents of the Journal of Endourology, Clinical Imaging, the
ournal of Urology, and Archives of Surgery.
he role of ESWL, PCNL and fURS in the management of complex
ediatric nephrolithiasis was reviewed including lower pole stone
r staghorn calculi, and solitary kidneys, as updated to 2013.
esults
ndourology and minimally invasive methods have progressively
eplaced open surgery, for the treatment of kidney stones, over
he past 30 years. Pediatric endourology has been replacing open
urgery too, with the first reported pediatric PCNL in 1984 and
SWL in 1986 [12,13]. The European Society of Pediatric Urology
p
o
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tCriteria related with the lowest SFR during ESWL for lower pole kidney
stone in a solitary kidney.
ESPU) recently published guidelines, recommending PCNL as the
reatment of choice in children with staghorn calculi, and ESWL
s a second line treatment [14]. Nevertheless, these recommenda-
ions need to always be tailored to the child’s anatomical factors,
ncluding the renal collecting system, in addition to the size of the
tone, exact location, and chemical composition. Children need not
o be excessively radiated too during these minimally invasive pro-
edures, therefore the shortest, fastest, and most efficient technique
s the one to adopt.
-ESWL
n adults as well as children ESWL has been adopted as a first option
or intermediate and small kidney stones. The limitation in a soli-
ary kidney would be mainly in the presence of a lower pole stone,
ecause of a lower stone-free rate (SFR) varying between 25 and
5%. Therefore, ESWL might be adopted, in a solitary kidney in
ase the stone is present in the upper or middle calyces. In the pres-
nce of a lower pole kidney stone, ESWL has been considered for
izes reaching a maximum of 1.5 cm; nevertheless, certain criteria
ould make this intervention less successful (Table 1).
n children, ESWL was introduced for the first time in 1986 [12],
nd Orsola et al. [15], in 1999, were the first to report ESWL as a
ingle therapy in children with staghorn calculi, rendering 11 out of
5 children stone-free.
FR are recently reaching higher rates, up to 88%, for children with
taghorn calculi, as reported by Lottmann et al. [16,17].
ecommendations for ESWL in children with staghorn calculi
iffer slightly from adults, since children have a smaller stone
urden in general, with smaller body volume and less abdominal
at, allowing a better shockwave transmission, resulting in higher
FR’s [15,17]. Therefore, some authors suggest that ESWL can
e offered as a single therapy in children with staghorn calculi
15,17]. It is a safe and effective technique as reported in large
eries of children, and despite some discouraging reports, ESWL
howed no evidence of renal scarring, renal function loss nor change
n blood pressure, as demonstrated in multiple studies [18,19],
nd as outlined in the recent reports of the (ESPU) [14]. Some
inor side effects are nonetheless reported, such as ecchymosis,
ematuria (40%) and renal colic (10–50%). When the stone is
ragmented, multiple small fragments can accumulate in the dis-
al ureter, causing again a secondary obstruction of the collecting
ystem, called “Steinstrasse”, and it may occur in the pediatric
opulation in 2–6% [20,21]. The major limitations of ESWL in
ediatric patients are mainly the need for multiple sessions, most
f them requiring general anesthesia, an increased clearance time,
bstruction resulting in renal colic, and a higher rate of admission
o the hospital.
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8Endourological therapies in pediatric nephrolithiasis
Concerning lower pole stones, by reviewing the literature, The SFR
after ESWL is lower in patients with a large stone burden or lower
pole stones [22], because gravity impedes the clearance of stone
fragments from lower pole calyces. [23]. Over the last two decades,
numerous anatomical factors have been identified resulting in low-
est clearance rates after ESWL, for lower pole stones (Table 1)
[24–28]. Even the skin-to-stone distance that has been thought to
be an important factor in the past is nowadays not accepted by all
authors [29–32].
New approaches have been implemented recently to minimize the
temporary damage to the kidney during ESWL [33,34]. These
techniques may be applied to children with solitary kidneys, and
include the use of a low-energy shockwave pretreatment, followed
by high energy treatment. It will induce a diffuse renal parenchy-
mal vasoconstriction during ESWL, instead of afterwards, as is the
case with no pretreatment [35]. Lowering the rate to 60/min also
improves stone fragmentation and minimizes parenchymal damage
[36]. Higher clearance rates are achieved in treating nephrolithiasis
in uninephric children.
Most centers and authors assess the SFR, after ESWL, at 3 months.
The reported SFRs at 3 months after ESWL for stones <10 mm,
10–20 mm, and >20 mm in diameter are 64–84%, 38–66%, and
25–49%, respectively [25,37–39]. Several authors have tried to com-
pare different modalities for the treatment of staghorn or lower
pole calculi in children with a solitary kidney. In 1994, Lingeman
et al. [40] did a meta-analysis and compared ESWL to PCNL, in
the management of lower pole stones. In that study, PCNL was
associated with a significantly higher SFR of 90%, compared to
59% with ESWL. Stone burden and size were negative factors
for the results of ESWL as expected. Furthermore, the “Lower
Pole Study Group” published a randomized controlled trial com-
paring ESWL with PCNL [41]. At 3 months follow-up PCNL
was associated with a high SFR of 97%, compared to only 37%
after ESWL. But when incorporating stone size, the SFR after
ESWL for stones of <10 mm was 63%, decreased to 21% for stones
between 10 and 20 mm, and 14% for those of >20 mm. Hospi-
tal stay was shorter for ESWL as well. The authors demonstrated
that ESWL was an acceptable method for lower poles stones of
<10 mm, but patients presenting with larger stones may benefit from
other endourological techniques especially in children with solitary
kidneys.
2-fURS
Over the past ten years, some new case series have been published,
on the role of ureteroscopy and mostly flexible ureteroscopy (fURS)
in the management of renal stones in children (Table 2) [42–50].
The main limitations of these case series are the small number of
cases reported, and the location of those stones, that is mainly in the
ureter, therefore providing less data on the complex stones in chil-
dren, represented by the lower pole stones, as published by Cannon
et al. [47] and Kim et al. [49]. Success rates as high as 98% and
100% were reported [43,45], however this SFR becomes smaller
(76%) when it involves lower pole stones, as reported by Cannon
et al. [47]. Dave et al. [48] reported a similar SFR reaching 75%
when it involved renal pelvis stones.In order to access lower pole kidney stones in children, the newest
generation of flexible ureteroscope represent an ideal tool. It may
be utilized safely in case of solitary kidney in children, however
t
[
s
s65
oncerns may exist in case of a large stone burden as in staghorn cal-
uli. Actually, fURS is recommended as a second-line treatment for
alculi of <10 mm, or as the third option for stones of 1–2 cm, by the
uidelines of the European Association of Urology (EAU). fURS is
ot recommended for stones of >2 cm [51]. The newest 2012 EAU
uidelines changed that [52]. While fURS was considered till now
second option for small stones, it has now been upgraded as an
lternative to PCNL for stones of intermediate size (1–2 cm). ESWL
as been downgraded to the second option for the management of
uch stones. Multiple improvements have been made, for the suc-
essful management of stones in the lower pole, while using fURS,
n particular the deflection mechanisms allowing better intrarenal
avigation [53]. Nowadays, the newest ureteroscopes have an outer
iameter of <9 F allowing direct access to the upper tract without
ilatation of the ureteral orifice [9,10,54–56]. Using access sheaths
lso facilitates this intervention and improves the results [57,58].
he newest generation of flexible endoscopes allowed the urologic
urgeon to make better use of fURS [59–62]. Consequently, Flex-
ble ureteroscopes have been used with great success in lower pole
tones in a solitary kidney. Digital ureteroscopes have been recently
ntroduced. They have a better resolution than the first generation
ber-optic endoscopes, since they include a camera chip at their tip,
esulting in the best visual quality, in addition to an incorporated
ight source [63]. In 2005, the Lower Pole Study Group published a
econd randomized controlled trial, and compared fURS to ESWL
or small lower-pole stones [64]. After 3 months, fURS did not have
better outcome statistically, when compared to ESWL (SFR 50%
s. 35%, fURS vs. ESWL, respectively). However, the length of
ospital stay, complication rates and the need for other secondary
rocedures were the same. But this study had some limitations. It
ncluded a limited number of patients, and 19 centers that recruited
atients with a different caseload and tools. In some recent studies,
uthors have reported that fURS could be considered for even
arger stones [38–41]. In some series, fURS achieved a high SFR
fter 1month, similar to that reached by PCNL [65–67].
reteroscopy in children has some technical aspects that need to be
aken into consideration. Ureteral dilatation was needed when large
igid ureteroscopes were used, as reported in the series of Bassiri
t al. [68], where most of the children had a ureteral dilatation when
1.5 French rigid ureteroscope was used. With the newest genera-
ion of flexible ureteroscope (4.5 French), ureteral dilatation is not
eeded, as published in the Philadelphia series [49]. The other tech-
ical issue is the need for ureteral stenting after stone removal. The
eed for ureteral stenting after stone removal remains controversial,
ut is determined by the stone burden, the degree of ureteral edema,
nd patient characteristics. Herndon et al. [69] stented 21% of the
hildren, and the main reasons were the need for subsequent ESWL,
reteral edema, perforation and stone impaction.
-PCNL
n the 1970s PCNL was adopted as a minimally invasive therapy for
arge kidney stones, and subsequently it has been optimized [70].
t has an excellent efficacy in the treatment of large staghorn cal-
uli, renal pelvic stones, in specifically lower-pole ones with a very
igh clearance rate [40]. It demonstrated an SFR of 100%, 93% and
6% for stones measuring <1 cm, 1–2 cm and larger stones, respec-
ively, in the Lower Pole I Study [41], in addition to other studies too
71,72]. To make PCNL even less invasive, mini-PCNL (using 18F
heaths, compared to 24-30F in regular PNCL) was introduced for
tones <2 cm in diameter [73–75]. Mini-PCNL has the advantage
66 N. Khater et al.
Table 2 Current published case series on the ureteroscopic management of pediatric nephrolithiasis.
Authors Number of children treated Ureteral stones Renal stones Stone size (mm) Success and stone-free rate (SFR)
Tan et al. [42] 23 25 2 9 95%
Minevich et al. [43] 58 58 7 patients N/A 98%
Thomas et al. [44] 29 28 1 patient 6 88%
Sofer et al. [45] 21 12 9 11 100%
Smaldone et al. [46] 100 67 33 8 91%
Cannon et al. [47] 21 0 Lower pole 12 76%
Dave et al. [48] 19 0 23
stones
17 Pelvic 75%
Polar 100%
Staghorn 14%
Kim et al. [49] 167 66 101 stones (87
lower pole)
6 100% if < 10 mm
97% if >10 mm
52 8 58%
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needs to have the best treatment in the armamentarium with the least
damage to the renal parenchyma [86,90–94].
Raza et al. [95] reviewed papers published between 1988 and 2003 in
the management of pediatric nephrolithiasis, by comparing the three
modalities, but not necessarily including complex stones. In gen-
eral, the authors concluded that renal stones <20 mm are effectively
treated by ESWL. For renal stones ≥20 mm or staghorn stones,
PCNL was the preferred primary modality, with high SFR (stone-
free rate). Ureteroscopy with holmium laser stone fragmentation
has high SFR, low complication rates, however this superiority was
demonstrated for ureteral stones only [95], and not for complex
cases (Table 3).
Regarding children with staghorn stones, ESWL seems to
have an increased rate of re-admissions, and multiple sessions.
Al-Busaidy et al. [96] reported an SFR reaching almost 80%,
where 42 children were treated, however adjunct procedures were
added to the final management, and this indicates that PCNL is a
valid alternative in the surgical treatment of children with staghorn
stones, as demonstrated in multiple published series (Table 4)
[15,17,84,96–99]. The issue of ureteral stenting after ESWL for
staghorn calculi in children is controversial. Al-Busaidy et al.
[96] reported that there were no differences in the stone-free rates
between stented and unstented children, however the unstented chil-
dren had more complications after the procedure. He recommended
routine ureteral stenting prior to ESWL in children with staghorn
Table 3 Comparison of outcomes including SFR (stone-free rate),
need for ancillary procedures and complication rate, for the three
different endourological modalities in pediatric nephrolithiasis, by
Raza et al. [95].
ESWL PCNL URS
Number of patients 122 37 35
Number of renal units 140 43 35
Mean age (years) 7.7 6.4 5.9
Number of treatments 209 46 53
Stone size (mm) 17 40 12
Associated ancillary procedures 45% 34% 26%
Complication rate 26% 6% 0%Tanaka et al. [50] 50 0
f causing less morbidity, less painful, with reduced bleeding [76].
everal studies have compared conventional PCNL to mini-PCNL
74,77,78]. The studies of Lahme et al. [74,79] emphasized the ques-
ion of whether mini-PCNL will result in an extension of the indi-
ations for percutaneous therapies. Nagele et al. [80] demonstrated
he safety of mini-PCNL even for smaller stones of 8–15 mm with
n excellent SFR. It seems to be the method of choice for staghorn
nd lower pole calculi, particularly in uninephric children. However,
urther prospective studies will need to assess this technique.
he first pediatric PCNL was reported in 1985 by Woodside et al.
13]. Some initial concerns, including parenchymal damage, expo-
ure to radiation, bleeding and sepsis [81–83], lead to a delay in
dopting this technique in children. Initial reports on PCNL in the
ediatric population emphasized that the main reason behind these
omplications was the use of large adult-sized catheters, sheaths,
nd devices, as demonstrated by Desai et al. [84], and Zeren et al.
85].
owever, with time leading to a higher learning curve, several recent
tudies showed that PCNL was not correlated with renal parenchy-
al damage, and that it was a safe technique in children with
taghorn calculi, as reported by Mor et al. [82], and by Dawaba
t al. [83].
iscussion
ediatric nephrolithiasis is a well known entity. It becomes more
roblematic in children who present with complex kidney stones,
ncluding staghorn calculi, stones in lower pole calyces, or the com-
ination of complex stones in uninephric patients.
taghorn stones are branched stones that typically fill the renal pelvis
ith branching into the calyces. They may be complete or par-
ial [86], and in pediatric population, like in adults, their chemical
omposition is magnesium ammonium phosphate (struvite), in the
ontext of infectious stones [87] and/or calcium carbonate apatite,
ess frequently uric acid or cystine. As in adult patients, treatment
f pediatric nephrolithiasis starts with treatment of the underlying
edical cause if it exists, like treatment of infections, to avoid recur-ence of any infectious stone [88,89]. Any cystine stone should be
reated with alkalinization and Tiopronin (Thiola®). The challenge
ecomes more problematic in the presence of staghorn calculi in
hildren with repetitive infections since the endourologic surgeon
SFR (Stone-free rate) 84% if
<20 mm
54% if
>20 mm
79% 100%
Endourological therapies in pediatric nephrolithiasis 67
Table 4 Overview and Comparison of PCNL and ESWL results in published series for the treatment of staghorn calculi in children.
Number of children treated in published series Age and/or stone characteristics SFR (%) (stone free rate)
PCNL
Desai et al. [84,142] Complete and partial staghorn 90%
Kumar et al. [97] Staghorn defined as occupying more than 1 calyx 92%
Gonen et al. [98] Complete and partial staghorn 68%
Aron et al. [99] Pre-school children 90%
ESWL
Orsola et al. [15] 1 year to 13 years 73%
Lottmann et al. [16] 5 months to 11 years 78%
Al-Busaidy et al. [96] 9 months to 12 years 79%
for the treatment of staghorn calculi in children.
but requires general anesthesia, and when compared to ESWL and
fURS, it has a higher rate of complications [117]. Srisubat et al.
[117] reported in 2009 an analysis of ESWL vs. URS vs. PCNL for
treating renal calculi. ESWL had the lowest efficacy while PCNL
and URS showed no statistical difference. It is obvious that the hos-
pital stay was shorter with ESWL, but all three treatments seemed
to offer a good chance of stone-free rate [38]. The available studies
had low quality data, because the authors included only three studies
in the meta-analysis.
First-line treatment for stones >1.5 cm in diameter, especially lower
pole stones, however some clinicians have reported that this tech-
nique is effective and safe. A combined approach in children (fURS+
PCNL) might be an alternative plan in certain institutions. However,
even in the presence of these combined techniques, PCNL seems to
have superiority in term of results and clearance rates, when com-
pared to fURS. In children who are not good candidates for PCNL,
fURS can be used [120]. Furthermore, in obese patients, the efficacy
of ESWL is limited, and PCNL can be technically impossible if the
needle is unable to reach the kidney, whereas fURS can be used
without these limitations [121].
Regarding children with stones in a solitary kidney, no major ran-
domized control trial assessed head to head the outcomes of PCNL
Kidney Stone 
in lower pole 
>2cm 
1-PCNL or fURS 
2-ESWL 
1-2cm 
Favorable 
factors for 
ESWL 
ESWL or  
Endourology 
1- Endourology 
2-ESWL 
<1cm 
1-ESWL 
2-fURS 
YES
NOOverview and comparison of PCNL and ESWL results in published series
calculi [96]. ESWL in children has been shown to expose the patient
to less radiation as compared to adults [18,21]. In general, children
aged less than 10 years will need general anesthesia during the ses-
sions of ESWL, whereas patients older than 10 years may benefit
from a light intravenous sedation [100]. Since staghorn calculi are
basically infectious stones, they represent a risk for recurrence in
children, especially after an initial session of ESWL. These recur-
rences seem to be higher when compared to adults, as reported by
Afshar el al. [90], reaching almost 35% at 4 years, and as demon-
strated by Nijman et al. [101].
PCNL is now considered the safest, fastest and first-line approach
for the treatment of staghorn calculi in adults [14,86], and with this
gain in experience and optimization of the instruments, PCNL is
becoming more adopted as a first-line treatment for staghorn cal-
culi in children [97], as reported in the guidelines of the AUA in
2005, and the ESPU in 2012 [14,86]. PCNL as monotherapy for
staghorn calculi can achieve SFRs of 60–100% in patients with
a wide age range [98,102,103], and Aron et al. demonstrated that
PCNL in children below age 10 has an SFR of 90% [99], and almost
100% as reported by Romanowsky et al. [104]. Nevertheless, PCNL
has a reported incidence of complications in pediatric population,
with a 25% risk of bleeding requiring transfusion as published by
Zeren et al. [85]. Stone burden and instrument size are related to
those complications, mostly bleeding, as reported by Kapoor et al.
[103]. While other complications are less dangerous (urinary leak,
fever. . .) [103,105–114], sepsis from large struvite staghorn stone
is the most serious complication, and can be lethal [115].
Regarding children with small lower-pole kidney stones, ESWL
seems to be the first option as a treatment modality [116], and this
may be extrapolated to solitary kidneys as well. Benefits include a
good SFR, minimal complications, and no need for general anes-
thesia if the child is above 10 years of age [25,38]. The updated
EAU Guidelines in 2012 (Fig. 1) [52] underlined that the treatment
outcome for stones of 1–2 cm depends on the predictive factors
(Table 1). If ESWL fails to clear the stone burden, endourological
approaches must be considered. Preliminary reports did not demon-
strate that fURS was superior to ESWL, but more recent reports
suggest that it has greater advantages [11,117,118]. A skilled uro-
logic surgeon will be able to have an almost 100% SFR when using
fURS in lower pole stone, and should be encouraged to use it more
in children with a solitary kidney. In addition to that, sometimes
ESWL is not an appropriate option in the presence of bleeding
dysfunction, children with elevated BMI, and unusual renal anatomy
[119]. In a lower pole stone of >1.5 cm in a solitary kidney, PCNL
seems to be the treatment of choice [37]. It has a very high SFR,
3-PCNL 
Figure 1 Management of lower pole kidney stone according to the
updated 2012 EAU guidelines.
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n comparison to fURS. An idea can be projected from the conclu-
ions of many studies performed on adult subject. One such study
as conducted by Kupajski et al. at the Medical University of Poland
122]. It was done to assess the risk factors that can affect the final
esult, PCNL and fURS in patients with a solitary kidney, taking into
onsideration the positioning, diameter and number of stones in the
rinary tract, and to assess the impact of the location of the stones
n the effectiveness of the minimally invasive treatment. In their
tudy, 51 patients operated between 1999 and 2008 in their urol-
gy department using PCNL and fURS due to stones located in the
yelo-calyceal system or the ureter were subjected to retrospective
ssessment. All patients had lost the contralateral kidney from previ-
us surgery. 34 PCNLs were performed on patients with a solitary
idney (66.7%). 17 patients required fURS (33.3%). PCNLs and
URS led to full recovery of 70.6% of patients. No complications
ere observed in 74.5% of patients with a single kidney. Signifi-
antly higher percentage of complications was observed in patients
ith two stones. The percentage of complications was also signifi-
antly higher in patients with 2 cm or bigger stones. Analysis of the
mpact of the positioning of stone showed that the location of the
tones did not affect the treatment result.
owever, there were significant differences in the occurrence of
omplications depending on the location of stones. Kupajski et al.
oncluded that the effectiveness of minimally invasive PCNL and
URS treatment of a solitary kidney is adversely affected by the size
f the stones and occurrence of more than one stone, which also
ncreases the percentage of complications, as does the positioning
f stones in calyces or in calyces and renal pelvis. Therefore, care
ust be taken when deciding which technique to consider in the
resence of stones in uninephric children.
n general, PCNL is considered the best treatment option for large
nd complex calculi [123]. High success rates of more than 90%
ave been reported [124], but bleeding is still one of the most
ommon complications; bleeding requiring a transfusion has been
eported between 0.8% and 45% in PCNL [125–127]. Most bleed-
ng related to PCNL has been managed conservatively, with 1% of
atients requiring angioembolization to control intractable bleeding
128].
l-Nahas et al. reported on a large experience with PCNL (3878
ases), in order to study risk factors for extensive post-PCNL bleed-
ng, and reported that the significant risk factors for severe bleeding
ncluded upper calyceal puncture, a staghorn stone, multiple punc-
ures, an inexperienced urologic surgeon and the presence of a
olitary kidney [129]. Therefore solitary kidneys containing a lower
ole stone could be a real technical challenge in children, based
n these reports. Operative time, tract size of the PCNL, and type
f lithotripter are other factors that influence bleeding [130]. The
mpact of PCNL on renal function is one of the most important
onsiderations. However, the confounding effects of the normal con-
ralateral kidney might preclude an accurate assessment of PCNL
ffects on renal function. Therefore, evaluating the impact of PCNL
n kidney function in children with solitary kidneys would be more
ccurate. Despite multiple reports in animal models about the impact
f PCNL on renal function using nuclear scintigraphy or serum/urine
iochemical analyses, few clinical studies have been performed
131,132].
kman et al. conducted a study in Turkey [133], in order to assess
he outcomes of PCNL in patients with solitary kidneys in regard to
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h
dN. Khater et al.
ransfusion requirements, complications, and renal function at early
nd late postoperative periods. And it will be important to consider
hose outcomes on a lower pole kidney stone in a uninephric child.
etween 2002 and 2009, 47 patients with a solitary kidney under-
ent PCNL in their medical center. Serum creatinine was measured
reoperatively, on postoperative day 1, and at each follow-up visit at
egular intervals. The 4-variable modification of diet in renal disease
quation was used to calculate the estimated glomerular filtration
ate (eGFR). The 5-stage classification of chronic kidney disease
CKD) was used according to the National Kidney Foundation pub-
ished guidelines. Success was achieved in 84.5% of patients after 1
ession of PCNL. Complex stones were present in 68.1% of patients.
mong all patients, multiple access tracts were required in 23.4% of
atients. Complications developed in 10.6% of patients. At a mean
ollow-up time of 18.7 months, the overall success rate improved
o 97.7% after auxiliary treatments. According to CKD classifica-
ion, kidney function was stable, improved and worse in 63.6%,
9.5%, and 6.8% of patients, respectively, compared with preoper-
tive levels. Akman et al. concluded that PCNL is safe and has a
ow complication rate in patients with solitary kidneys. At long-term
ollow-up, renal function had stabilized or improved in more than
0% of patients with a solitary kidney after PCNL, and it should be
onsidered the treatment of choice in children with lower pole stone
n solitary kidneys.
onetheless, in order to minimize the undesired effect of multi-
le accesses on bleeding, the combined flexible nephroscope or
reteroscopic techniques with a single percutaneous access may
e adopted instead of multiple accesses. Marguet et al. reported
hat though combined PCNL and ureteroscopic management can
ffectively decrease the number of the access tracts, this combined
rocedure does not significantly affect stone-free rate and operative
ime [134].
urthermore, although a 30-F tract was routinely used in the Turkish
tudy of Akman et al., using smaller tract size may be less traumatic
n kidneys with non-dilated calices and narrow infundibula, and it
ay reduce bleeding during PCNL in children. For PCNL therapy
erformed on a solitary kidney, the mini-perc and/or combination of
ingle access and flexible instruments may be preferred. In contrast,
conservative approach using a single instead of multiple access
racts may be preferable.
n the other hand, only a few studies have studied the factors affect-
ng renal function in patients with solitary kidneys in the late post-
CNL period. Mayo et al. assessed renal function with radionuclide
tudies and evaluated creatinine clearances in 15 patients with a nor-
al contralateral kidney 2–3 months after PCNL and demonstrated
mprovements of renal function, especially in patients with infected
tones [135]. Another study also revealed that female gender is one
f the most important predictive factors for the preservation of renal
unction after PCNL [131]. The authors concluded that young girls
re 3 times more likely to manifest improved renal functional out-
omes 1 year postoperatively [131]. In contrast, Akman et al. [133]
ound no significant correlation between postoperative kidney func-
ion and patient-related factors, like gender, presence of obesity,
revious open kidney surgery, or grade of hydronephrosis.nother very important factor that needs to be considered in PCNL
s treating children with lower pole stones in a single kidney which
as a potential effect on renal function from multiple access proce-
ures. In the retrospective study of Akman et al. [133], the authors
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demonstrated that renal function in the early and late postopera-
tive periods was not clinically affected by the creation of multiple
tracts. Kidney function during the late postoperative period dete-
riorated in 1 of the 12 patients who had undergone PCNL with
multiple accesses. Traxer et al. compared the extent of renal injury
incurred by different sized nephrostomy tracts in female farm pigs
undergoing 11- or 30-F percutaneous nephrostomies [136]. They
reported a mean estimated scar volume of the 30- and 11-F tracts
of 0.29 and 0.40 mL. Recently, the negative effects of shock wave
lithotripsy, percutaneous nephrolithotomy and non-interventional
observation were compared among adult patients with asymp-
tomatic lower calyceal stones [137]. Results can give us an idea
and might be extrapolated to solitary kidneys in children as well,
pending a comparison of complication of each technique in the pedi-
atrics population. All patients in the adult study were evaluated by
renal scintigraphy at 6 weeks and 1 year after the intervention. At
follow-up, scintigraphy revealed lower pole scarring in 16.1% of
cases in the ESWL group, and lower pole access site scarring was
reported in 1 patient in the PCNL group [137]. Finally, in another
study, Liou and Streem found no significant difference between esti-
mated creatinine clearances in patients with solitary kidneys who
had undergone PCNL, shock wave lithotripsy or combined therapies
[138].
In 2011, Resorlu et al. [139] evaluated the safety and efficacy of
PCNL in the treatment of complex calyceal or staghorn stones in a
solitary kidney and determined long-term renal functional results.
The authors presented their experience with PCNL in treating 16
patients with staghorn stones in a solitary kidney to determine
long-term renal functional results. They retrospectively reviewed
the records of 16 patients, including young patients, with com-
plex calyceal or staghorn stones in a solitary kidney treated with
PCNL. Of these, 62.5% patients required a single tract, while 37.5%
required multiple tracts. The calculi were extracted or fragmented
successfully in 81.3% patients and complete stone clearance was
achieved after the first stage. In two patients with residual calculi,
a ureteral catheter was inserted and ESWL was performed. There
were no significant intra-operative problems except in one patient,
who had bleeding from an infundibular tear attributable to torquing.
During the 1-year study period, none of the patients progressed to
end-stage renal disease requiring dialysis. The authors demonstrated
a significant improvement in creatinine and GFR levels from preop-
eratively to 1-year follow-up. In this study the demonstrated efficacy,
low short-term complication rate and absence of long-term adverse
effects on renal function confirm that PCNL is effective and safe in
staghorn and lower pole calculi in the solitary kidney, and this may
also be the case in children.
In summary, several studies have been published in order to assess
minimally invasive therapies for the management of staghorn cal-
culi, lower pole stones and stones in uninephric children. However,
we lack randomized controlled studies comparing PCNL, ESWL,
and fURS.
Patients presenting with lower pole stones in solitary kidneys remain
problematic. A combined technique termed ‘sandwich therapy’,
which consisted of primary percutaneous stone debulking fol-
lowed by ESWL of any inaccessible, residual infundibulocalyceal
stone fragments. However, improved PCNL techniques, achieved
complete clearance of stone material at the time of the primary pro-
cedure, have decreased or eliminated the need for additional ESWL
treatment, especially in children [140–142].69
or renal stones less than 20 mm in size, fURS is an excellent
inimally invasive technique with high SFR. Recently, new publi-
ations report that fURS is a viable treatment for large renal calculi
143–145]. A disadvantage of fURS is that several interventions
ay be required to clear a large stone burden. Overall, fURS has
ewer complications when compared to PCNL [146,147].
onclusion
hildren with staghorn calculi, stones in lower poles, and stones in
solitary kidney are among the most challenging cases in endourol-
gy.
ninephric children with renal stones of <10 mm are usually suc-
essfully treated with ESWL; larger stones, especially within the
ower pole, are more efficiently treated by PCNL. fURS is recom-
ended as a second-line alternative treatment for smaller lower-pole
tones and as an alternative for stones of moderate size if there are
egative predictors for the success of ESWL. Nevertheless, fURS is
eing used for such stones by urologic surgeons. For renal stones less
han 20 mm in size, fURS is an excellent minimally invasive tech-
ique with high SFR, especially in lower pole stones in uninephric
hildren. PCNL is a safe procedure with a high SFR, and an accept-
bly low complication rate in children presenting with large staghorn
alculi or lower pole stones in a solitary kidney. Multiple access
racts slightly increase the risk of complications, such as the risk of
lood transfusion, but they do not represent a major obstacle in a
oung healthy child; furthermore, in the case of lower pole stones
n a solitary kidney, multiple tract access does not seem to lead to a
eduction in renal function, when compared to a single-tract access.
inally, in the presence of this wide armamentarium, surgeon’s pref-
rences are to be added to the choice of the best therapy. More
rospective, randomized studies with large patient numbers are
equired, in addition to the development of new surgical devices and
inimally invasive endourological techniques to optimize endouro-
ogical therapy.
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